Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
110.00
+3.34 (3.13%)
Sep 30, 2026, 3:00 PM CST
SHA:688266 Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, SHA:688266 stock has a consensus rating of "Strong Buy" and an average price target of ¥141.07. The average 1-year stock price forecast is 28.25% higher than the current stock price, while the lowest is ¥121.07 (+10.06%) and the highest is ¥161.08 (+46.44%).
Price Target: ¥141.07 (+28.25%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for SHA:688266 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Mar '26 | Apr '26 | Jun '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 4 | 3 | 3 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 5 | 4 | 4 | 3 |
Financial Forecast
Revenue This Year
1.81B
from 810.48M
Increased by 123.49%
Revenue Next Year
1.84B
from 1.81B
Increased by 1.51%
EPS This Year
2.18
from -0.75
EPS Next Year
1.25
from 2.18
Decreased by -42.66%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.